SFS
CORT icon

Sowell Financial Services’s Corcept Therapeutics CORT Stock Holding History

Sowell Financial Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-792
Closed -$17K – 951
2021
Q1 		$17K Buy
792
+723
+1,048% +$19.3K ﹤0.01% 2111
2020
Q4 		$2K Hold
69
– – ﹤0.01% 2452
2020
Q3 		$1K Hold
69
– – ﹤0.01% 2336
2020
Q2 		$1K Sell
69
-5,000
-99% -$70.2K ﹤0.01% 2262
2020
Q1 		$60K Buy
5,069
+69
+1% +$854 ﹤0.01% 995
2019
Q4 		$60K Hold
5,000
– – ﹤0.01% 1093
2019
Q3 		$71K Buy
+5,000
New +$61.4K 0.01% 912

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sowell Financial Services's CORT Position: Q2 2021 in Review

Sowell Financial Services sold out of Corcept Therapeutics (CORT) in Q2 2021, closing a stake of 792 shares — an estimated $17K sold.

Sowell Financial Services first reported a position in CORT in Q3 2019 and held it in 7 quarters. The position peaked at $71K in Q3 2019. 199 funds tracked by Wall St. Rank hold CORT as of Q2 2021.

  • Sowell Financial Services reported no remaining Corcept Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 792 Corcept Therapeutics shares in Q2 2021, an estimated $17K.
  • Sowell Financial Services first reported a position in Corcept Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Corcept Therapeutics position peaked at $71K in Q3 2019.
  • 199 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.